InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Kropotova Alexandra, Directeur Médical. Insider active across 1 company, notably SAB Biotherapeutics, Inc.. In total, 5 reports have been recorded. Activity tracked since 6 June 2022. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Alexandra Kropotova is the Chief Medical Officer at SAB Biotherapeutics, Inc. She is responsible for leading the company's medical initiatives and research strategy. Alexandra brings clinical and scientific expertise to support the development of innovative products.